Related Experiment Videos

Effect of an exchange transfusion on plasma antioxidants in the newborn

J H Lindeman1, E G Lentjes, E Houdkamp

  • 1Department of Pediatrics, University Hospital, Leiden, The Netherlands.

Pediatrics
|August 1, 1992
PubMed

Insights

Exchange transfusion in newborns with rhesus hemolytic disease altered plasma antioxidants. While some antioxidants increased, others decreased, impacting free radical metabolism.

Area of Science:

  • Neonatal Medicine
  • Biochemistry
  • Pediatric Hematology

Background:

  • Rhesus hemolytic disease is a condition in newborns requiring intervention.
  • Exchange transfusion is a common treatment for severe neonatal jaundice and hemolytic disease.
  • The impact of exchange transfusion on plasma antioxidant status in newborns is not fully understood.

Purpose of the Study:

  • To investigate the effects of exchange transfusion on plasma antioxidant concentrations in newborns with rhesus hemolytic disease.
  • To assess changes in both primary and secondary antioxidants post-transfusion.
  • To evaluate the influence of exchange transfusion on lipid peroxidation.

Main Methods:

  • Plasma samples were collected from newborns before and after exchange transfusion.
  • Concentrations of various antioxidants including vitamin C, uric acid, thiols, vitamin E, ceruloplasmin, and transferrin were measured.
  • Iron, ferritin, and latent iron-binding capacity were also assessed.
  • Thiobarbituric acid reactive substances (TBARS) were measured as an indicator of lipid peroxidation.

Main Results:

  • Exchange transfusion led to decreased iron and ferritin levels and increased ceruloplasmin and transferrin concentrations.
  • Secondary antioxidant levels showed variable changes: vitamin C and bilirubin decreased, vitamin E increased, while uric acid and thiols remained stable.
  • The total peroxyl-radical trapping capacity of secondary antioxidants did not change significantly.
  • A decrease in thiobarbituric acid reactive substances (TBARS) was observed, correlating with lower levels in donor blood.

Conclusions:

  • Exchange transfusion causes rapid and variable alterations in plasma prooxidant and antioxidant profiles in newborns with rhesus hemolytic disease.
  • These changes may significantly influence the newborn's free radical metabolism.
  • The study highlights the complex biochemical shifts occurring during exchange transfusion therapy.

Related Concept Videos